NO20070599L - Anvendelse av C3a og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt diagnosemetoder og testsytem som anvender samme. - Google Patents

Anvendelse av C3a og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt diagnosemetoder og testsytem som anvender samme.

Info

Publication number
NO20070599L
NO20070599L NO20070599A NO20070599A NO20070599L NO 20070599 L NO20070599 L NO 20070599L NO 20070599 A NO20070599 A NO 20070599A NO 20070599 A NO20070599 A NO 20070599A NO 20070599 L NO20070599 L NO 20070599L
Authority
NO
Norway
Prior art keywords
carcinoma
colorectal
colorectal adenoma
biomarker
well
Prior art date
Application number
NO20070599A
Other languages
English (en)
Inventor
Hartmut Juhl
Kerstin David
Anne-Kristin Fentz
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070599(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Publication of NO20070599L publication Critical patent/NO20070599L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Det beskrives en fremgangsmåte for å detektere kolorektal adenom og/eller kolorektal karsinom omfattende trinnene: a) tilveiebringe et isolert prøvemateriale som har blitt hentet fra et individ, b) bestemme nivået av C3a eller et derivat derav i nevnte isolerte prøvemateriale, c) sammenlikne det bestemte nivå av C3a eller et derivat derav med én eller flere referanseverdier. Oppfinnelsen er ytterligere rettet mot en fremgangsmåte for å diskriminere mellom kolorektal adenom og kolorektal karsinom og likeledes en fremgangsmåte for å monitorere forløpet av kolorektal adenom og/eller kolorektal karsinom og/eller behandlingen av kolorektal adenom og/eller kolorektal karsinom. Videre beskrives et testsystem og et arrangement for anvendelse i disse metoder. Videre, oppfinnelsen vedrører anvendelse av C3a som en biomarkør for deteksjon av kolorektal adenom og/eller kolorektal karsinom i et individ. Videre, oppfinnelsen vedrører fremgangsmåte for å bestemme om en forbindelse er effektiv i behandling av kolorektal adenom og/eller kolorektal karsinom.
NO20070599A 2004-08-13 2007-01-31 Anvendelse av C3a og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt diagnosemetoder og testsytem som anvender samme. NO20070599L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2004/009124 WO2006015616A1 (en) 2004-08-13 2004-08-13 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
PCT/EP2005/008742 WO2006053592A1 (en) 2004-08-13 2005-08-11 Use of c3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same

Publications (1)

Publication Number Publication Date
NO20070599L true NO20070599L (no) 2007-05-14

Family

ID=34958684

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20070598A NO20070598L (no) 2004-08-13 2007-01-31 Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem
NO20070599A NO20070599L (no) 2004-08-13 2007-01-31 Anvendelse av C3a og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt diagnosemetoder og testsytem som anvender samme.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20070598A NO20070598L (no) 2004-08-13 2007-01-31 Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem

Country Status (20)

Country Link
US (2) US7951528B2 (no)
EP (3) EP1761779B1 (no)
JP (2) JP4916441B2 (no)
KR (1) KR20070051328A (no)
CN (2) CN101014859A (no)
AT (2) ATE376674T1 (no)
AU (2) AU2004322162B2 (no)
BR (1) BRPI0419002A (no)
CA (2) CA2577601A1 (no)
DE (2) DE602004009716T2 (no)
DK (2) DK1761779T3 (no)
ES (2) ES2295907T3 (no)
IL (2) IL181131A (no)
MX (2) MX2007001479A (no)
NO (2) NO20070598L (no)
PL (2) PL1761779T3 (no)
PT (2) PT1761779E (no)
SI (1) SI1776587T1 (no)
WO (2) WO2006015616A1 (no)
ZA (1) ZA200701188B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1761779T3 (pl) 2004-08-13 2008-04-30 Indivumed Gmbh Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
JP4748671B2 (ja) * 2006-03-16 2011-08-17 日東紡績株式会社 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
JP5570810B2 (ja) * 2007-08-18 2014-08-13 学校法人北里研究所 大腸癌マーカポリペプチド、及び大腸癌の診断方法
JP5203687B2 (ja) * 2007-12-12 2013-06-05 シスメックス株式会社 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム
CN101838683B (zh) * 2008-12-12 2013-09-18 深圳华大基因科技有限公司 一种kras基因和/或braf基因的核苷酸突变位点的检测方法
CN102147396B (zh) * 2010-02-10 2014-01-01 桑建利 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用
JP2013253780A (ja) * 2010-10-12 2013-12-19 Katakura Industries Co Ltd うつ病の診断のためのデータの提供方法
US10158898B2 (en) 2012-07-26 2018-12-18 Comcast Cable Communications, Llc Customized options for consumption of content
EP2926138A4 (en) * 2012-11-30 2016-09-14 Applied Proteomics Inc METHOD FOR ASSESSING THE PRESENCE OR RISK OF COLON TUMORS
CN104056277B (zh) * 2013-03-21 2019-07-05 中国人民解放军第二军医大学 Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用
SG11201608053PA (en) * 2014-03-28 2016-10-28 Applied Proteomics Inc Protein biomarker profiles for detecting colorectal tumors
EP3183578B8 (en) * 2014-08-22 2020-07-15 Abbott Laboratories Methods for the early detection of colorectal cancer
CN105988006A (zh) * 2015-02-10 2016-10-05 张曼 尿液补体c3蛋白的应用
US9689874B2 (en) 2015-04-10 2017-06-27 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
GB201721569D0 (en) * 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
GB201808476D0 (en) * 2018-05-23 2018-07-11 Univ Liverpool Biomarkers for colorectal cancer
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
EP4407042A3 (en) 2020-07-10 2024-09-18 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
CN116449018B (zh) * 2023-02-14 2023-09-05 浙江大学 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
DE19711111C2 (de) 1997-03-06 1999-09-02 Schering Ag In vitro Nachweis zur Erkennung von Darmtumoren
US6221621B1 (en) 1997-03-06 2001-04-24 Bard Diagnostic Sciences, Inc. Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
IL121134A0 (en) * 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
WO2002059621A2 (en) 2001-01-24 2002-08-01 Bayer Corporation Regulation of transthyretin to treat obesity
WO2003000182A2 (en) 2001-06-22 2003-01-03 Merck & Co., Inc. Ppar-alpha ligands for the treatment or prevention of cachexia
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
DE10224534A1 (de) 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
WO2004001072A2 (en) 2002-06-19 2003-12-31 Oncotherapy Science, Inc. Method for diagnosis of colorectal tumors
US7605003B2 (en) 2002-08-06 2009-10-20 The Johns Hopkins University Use of biomarkers for detecting ovarian cancer
EP1895302A3 (en) * 2003-04-08 2008-05-14 Colotech A/S A method of detecting of colorectal cancer in human samples
US7268117B2 (en) * 2003-07-11 2007-09-11 Praecis Pharmaceuticals Incorporated Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
BRPI0419004A (pt) 2004-08-13 2007-12-11 Egomedical Technologies Ag sistema de testes de analitos para determinar a concentração de um analito em um fluido fisiológico ou aquoso
PL1761779T3 (pl) 2004-08-13 2008-04-30 Indivumed Gmbh Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy
US9075062B2 (en) 2005-03-22 2015-07-07 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Identification of biomarkers by serum protein profiling

Also Published As

Publication number Publication date
IL181132A (en) 2011-04-28
IL181131A (en) 2011-03-31
DE602005012108D1 (de) 2009-02-12
AU2005306103A1 (en) 2006-05-26
IL181132A0 (en) 2007-07-04
KR20070051328A (ko) 2007-05-17
EP1776587B9 (en) 2009-09-16
US7883842B2 (en) 2011-02-08
EP1776587B1 (en) 2008-12-31
JP2008509409A (ja) 2008-03-27
SI1776587T1 (sl) 2009-06-30
CA2576998A1 (en) 2006-05-26
DE602004009716D1 (de) 2007-12-06
EP1843159A1 (en) 2007-10-10
CA2577601A1 (en) 2006-02-16
WO2006053592A1 (en) 2006-05-26
ES2322378T3 (es) 2009-06-19
WO2006015616A1 (en) 2006-02-16
NO20070598L (no) 2007-05-14
CN101014859A (zh) 2007-08-08
PL1776587T3 (pl) 2009-06-30
JP2008509407A (ja) 2008-03-27
MX2007001254A (es) 2007-10-05
US20070184499A1 (en) 2007-08-09
ES2295907T3 (es) 2008-04-16
PT1776587E (pt) 2009-04-03
BRPI0419002A (pt) 2007-12-11
US7951528B2 (en) 2011-05-31
EP1761779A1 (en) 2007-03-14
PT1761779E (pt) 2008-02-01
PL1761779T3 (pl) 2008-04-30
IL181131A0 (en) 2007-07-04
DK1776587T3 (da) 2009-04-20
CN101014861A (zh) 2007-08-08
DE602004009716T2 (de) 2008-08-28
AU2004322162A1 (en) 2006-02-16
US20080160515A1 (en) 2008-07-03
ATE419534T1 (de) 2009-01-15
EP1776587A1 (en) 2007-04-25
EP1761779B1 (en) 2007-10-24
JP4916441B2 (ja) 2012-04-11
AU2004322162A2 (en) 2006-02-16
MX2007001479A (es) 2007-07-25
DK1761779T3 (da) 2008-02-25
ZA200701188B (en) 2009-01-28
JP4592753B2 (ja) 2010-12-08
AU2004322162B2 (en) 2011-04-28
ATE376674T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
NO20070599L (no) Anvendelse av C3a og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt diagnosemetoder og testsytem som anvender samme.
US9884269B2 (en) Methods and systems for selective hydrogen gas extraction for dissolved gas analysis applications
RU2018124339A (ru) Способ и система для сенсорного обнаружения посредством модифицированной наноструктуры
JP2015514987A5 (no)
DE602004009590D1 (de) Verfahren zur empfängerautonomen integritätsüberwachung und fehlerdetektion und -beseitigung
WO2007005666A3 (en) System and method of analyte detection using differential receptors
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
BRPI0814201A2 (pt) Sistema e método de análise de produto de análise em amostra fluida e meio legível em computador
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
AR058900A1 (es) Metodo para determinar la identidad o no identidad y la concentracion de un compuesto quimico en un medio
MX2021008520A (es) Metodos y sistemas para deteccion de analitos.
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
JP2020514689A5 (no)
NO20080510L (no) Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
WO2007062142A3 (en) Method for identifying biomarkers associated with cancer
WO2006019991A3 (en) Method and apparatus for multimodal detection
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
EP2017642A3 (fr) Procédé et dispositif de détection et de mesure de paramètres de signaux radioélectriques
BRPI0514314A (pt) método para detecção de e discriminação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento de desenvolvimento e/ou curso e/ou de tratamento de adenoma colorretal e/ou carcinoma colorretal, uso de c3a ou derivado do mesmo, sistema de teste, conjunto compreendendo moléculas, método para determinar se um composto é efetivo no tratamento do adenoma colorretal e/ou carcinoma colorretal
MX2017008959A (es) Biomarcadores relacionados con la funcion del riñon y metodos que involucran su uso.
WO2008060676A3 (en) System and method for resolving gamma-ray spectra

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application